Home / Inspections / 1027124

FDA Inspection 1027124 — Andrzej Galaj, MD

Andrzej Galaj, MD — FEI 3013658665

The FDA completed an inspection of Andrzej Galaj, MD on Aug 25, 2017 in Bydgoszcz. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Aug 25, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Bydgoszcz (Poland)

Additional Details

Clinical Investigator (CI)

Facility

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.